Serpentine supravenous hyperpigmentation in association with anti-TIF1-gamma antibody-positive myositis

被引：0
|
作者：
Richardson, William M. [1 ]
Zampella, John G. [1 ]
Meehan, Shane A.
Femia, Alisa N. [1 ]
机构：
[1] NYU Langone Hlth, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2024年
关键词：
inflammatory myopathies; TIF1-gamma autoantibodies; serpentine supravenous hyperpigmentation; COVID-19; vaccination; SARS-CoV-2; skin of color (SOC);
D O I：
10.1111/ijd.17391
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Clinicopathological characteristics of anti-TIF1-gamma antibody-positive dermatomyositis
    Yamanaka, A.
    Eura, N.
    Yamaoka, M.
    Ozaki, M.
    Shiota, T.
    Nanaura, H.
    Sugie, K.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S51 - S51
  • [2] Effectiveness of IVIG and balloon dilation combination therapy for refractory dysphagia in anti-TIF1-gamma antibody-positive dermatomyositis
    Utsunomiya, Akira
    Koizumi, Haruka
    Iino, Shiro
    Takashima, Wataru
    Tokuriki, Atsushi
    Tokunaga, Takahiro
    Kobayashi, Namiko
    Hamaguchi, Yasuhito
    Hasegawa, Minoru
    MODERN RHEUMATOLOGY CASE REPORTS, 2018, 2 (01) : 49 - 53
  • [3] Anti-TIF1-γ antibody-positive dermatomyositis
    Li, Chia-Lun
    Ma, Sheng-Hsiang
    Wu, Chen-Yi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (12) : 2583 - 2584
  • [4] Cutaneous ulceration in dermatomyositis. Case reports with positive anti-NXP-2/anti-TIF1-gamma antibody status
    Wald, Caroline
    Simon, Jan-Christoph
    Treudler, Regina
    DERMATOLOGIE, 2025, 76 (02): : 97 - 100
  • [5] Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment
    Lerman, Irina
    Richardson, Christopher T.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (09)
  • [6] Transcriptional intermediary factor 1 (TIF1) and anti-TIF1γ antibody-positive dermatomyositis
    Kotobuki, Yorihisa
    Tonomura, Kyoko
    Fujimoto, Manabu
    IMMUNOLOGICAL MEDICINE, 2021, 44 (01) : 23 - 29
  • [7] Amyopathic anti-TIF1-γ antibody-positive dermatomyositis in a young man
    Kluger, Nicolas
    JEADV CLINICAL PRACTICE, 2024, 3 (03): : 891 - 894
  • [8] Changes in antibody titres in patients with anti transcription intermediary factor 1-gamma antibody-positive idiopathic inflammatory myositis
    Abe, Yoshiyuki
    Ando, Taiki
    Matsushita, Masakazu
    Tada, Kurisu
    Yamaji, Ken
    Tamura, Naoto
    RHEUMATOLOGY, 2019, 58 (01) : 179 - 181
  • [9] Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy
    Harada, Yumi
    Tominaga, Masaki
    Iitoh, Eriko
    Kaieda, Shinjiro
    Koga, Takuma
    Fujimoto, Kiminori
    Chikasue, Tomonori
    Obara, Hitoshi
    Kakuma, Tatsuyuki
    Ida, Hiroaki
    Kawayama, Tomotaka
    Hoshino, Tomoaki
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [10] Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence
    Ferronato, Marco
    Lalanne, Claudine
    Quarneti, Chiara
    Cevolani, Michele
    Ricci, Chiara
    Granito, Alessandro
    Muratori, Luigi
    Lenzi, Marco
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (01) : 253 - 259
12345